Report cover image

Global Drug-Loadable Embolic Microspheres Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 198 Pages
SKU # APRC20282773

Description

Summary

According to APO Research, The global Drug-Loadable Embolic Microspheres market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Drug-Loadable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Drug-Loadable Embolic Microspheres include Suzhou Hengrui Medical Equipment, Cardiolink Science, Varian, Terumo, Sirtex Medical, Merit Medical, Boston Scientific and ABK Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drug-Loadable Embolic Microspheres, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Drug-Loadable Embolic Microspheres, also provides the sales of main regions and countries. Of the upcoming market potential for Drug-Loadable Embolic Microspheres, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug-Loadable Embolic Microspheres sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Drug-Loadable Embolic Microspheres market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Drug-Loadable Embolic Microspheres sales, projected growth trends, production technology, application and end-user industry.

Drug-Loadable Embolic Microspheres Segment by Company

Suzhou Hengrui Medical Equipment
Cardiolink Science
Varian
Terumo
Sirtex Medical
Merit Medical
Boston Scientific
ABK Biomedical
Drug-Loadable Embolic Microspheres Segment by Type

Radioactive Microspheres
Drug-eluting Microspheres
Drug-Loadable Embolic Microspheres Segment by Application

Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others
Drug-Loadable Embolic Microspheres Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Loadable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug-Loadable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Loadable Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Drug-Loadable Embolic Microspheres in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Drug-Loadable Embolic Microspheres manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Loadable Embolic Microspheres sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Drug-Loadable Embolic Microspheres Market by Type
1.2.1 Global Drug-Loadable Embolic Microspheres Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Radioactive Microspheres
1.2.3 Drug-eluting Microspheres
1.3 Drug-Loadable Embolic Microspheres Market by Application
1.3.1 Global Drug-Loadable Embolic Microspheres Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Primary Liver Cancer
1.3.3 Colorectal Cancer Liver Metastasis
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Drug-Loadable Embolic Microspheres Market Dynamics
2.1 Drug-Loadable Embolic Microspheres Industry Trends
2.2 Drug-Loadable Embolic Microspheres Industry Drivers
2.3 Drug-Loadable Embolic Microspheres Industry Opportunities and Challenges
2.4 Drug-Loadable Embolic Microspheres Industry Restraints
3 Global Market Growth Prospects
3.1 Global Drug-Loadable Embolic Microspheres Revenue Estimates and Forecasts (2020-2031)
3.2 Global Drug-Loadable Embolic Microspheres Revenue by Region
3.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Drug-Loadable Embolic Microspheres Revenue by Region (2020-2025)
3.2.3 Global Drug-Loadable Embolic Microspheres Revenue by Region (2026-2031)
3.2.4 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2020-2031)
3.3 Global Drug-Loadable Embolic Microspheres Sales Estimates and Forecasts 2020-2031
3.4 Global Drug-Loadable Embolic Microspheres Sales by Region
3.4.1 Global Drug-Loadable Embolic Microspheres Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Drug-Loadable Embolic Microspheres Sales by Region (2020-2025)
3.4.3 Global Drug-Loadable Embolic Microspheres Sales by Region (2026-2031)
3.4.4 Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers
4.1.1 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers (2020-2025)
4.1.2 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Drug-Loadable Embolic Microspheres Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers
4.2.1 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (2020-2025)
4.2.2 Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Drug-Loadable Embolic Microspheres Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Drug-Loadable Embolic Microspheres Sales Price by Manufacturers (2020-2025)
4.4 Global Drug-Loadable Embolic Microspheres Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Drug-Loadable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Drug-Loadable Embolic Microspheres Manufacturers, Product Type & Application
4.7 Global Drug-Loadable Embolic Microspheres Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Drug-Loadable Embolic Microspheres Market CR5 and HHI
4.8.2 2024 Drug-Loadable Embolic Microspheres Tier 1, Tier 2, and Tier 3
5 Drug-Loadable Embolic Microspheres Market by Type
5.1 Global Drug-Loadable Embolic Microspheres Revenue by Type
5.1.1 Global Drug-Loadable Embolic Microspheres Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2020-2031)
5.2 Global Drug-Loadable Embolic Microspheres Sales by Type
5.2.1 Global Drug-Loadable Embolic Microspheres Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Drug-Loadable Embolic Microspheres Sales by Type (2020-2031) & (K Units)
5.2.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2020-2031)
5.3 Global Drug-Loadable Embolic Microspheres Price by Type
6 Drug-Loadable Embolic Microspheres Market by Application
6.1 Global Drug-Loadable Embolic Microspheres Revenue by Application
6.1.1 Global Drug-Loadable Embolic Microspheres Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2020-2031)
6.2 Global Drug-Loadable Embolic Microspheres Sales by Application
6.2.1 Global Drug-Loadable Embolic Microspheres Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Drug-Loadable Embolic Microspheres Sales by Application (2020-2031) & (K Units)
6.2.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2020-2031)
6.3 Global Drug-Loadable Embolic Microspheres Price by Application
7 Company Profiles
7.1 Suzhou Hengrui Medical Equipment
7.1.1 Suzhou Hengrui Medical Equipment Comapny Information
7.1.2 Suzhou Hengrui Medical Equipment Business Overview
7.1.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Portfolio
7.1.5 Suzhou Hengrui Medical Equipment Recent Developments
7.2 Cardiolink Science
7.2.1 Cardiolink Science Comapny Information
7.2.2 Cardiolink Science Business Overview
7.2.3 Cardiolink Science Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Cardiolink Science Drug-Loadable Embolic Microspheres Product Portfolio
7.2.5 Cardiolink Science Recent Developments
7.3 Varian
7.3.1 Varian Comapny Information
7.3.2 Varian Business Overview
7.3.3 Varian Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Varian Drug-Loadable Embolic Microspheres Product Portfolio
7.3.5 Varian Recent Developments
7.4 Terumo
7.4.1 Terumo Comapny Information
7.4.2 Terumo Business Overview
7.4.3 Terumo Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Terumo Drug-Loadable Embolic Microspheres Product Portfolio
7.4.5 Terumo Recent Developments
7.5 Sirtex Medical
7.5.1 Sirtex Medical Comapny Information
7.5.2 Sirtex Medical Business Overview
7.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Product Portfolio
7.5.5 Sirtex Medical Recent Developments
7.6 Merit Medical
7.6.1 Merit Medical Comapny Information
7.6.2 Merit Medical Business Overview
7.6.3 Merit Medical Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Merit Medical Drug-Loadable Embolic Microspheres Product Portfolio
7.6.5 Merit Medical Recent Developments
7.7 Boston Scientific
7.7.1 Boston Scientific Comapny Information
7.7.2 Boston Scientific Business Overview
7.7.3 Boston Scientific Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Boston Scientific Drug-Loadable Embolic Microspheres Product Portfolio
7.7.5 Boston Scientific Recent Developments
7.8 ABK Biomedical
7.8.1 ABK Biomedical Comapny Information
7.8.2 ABK Biomedical Business Overview
7.8.3 ABK Biomedical Drug-Loadable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 ABK Biomedical Drug-Loadable Embolic Microspheres Product Portfolio
7.8.5 ABK Biomedical Recent Developments
8 North America
8.1 North America Drug-Loadable Embolic Microspheres Market Size by Type
8.1.1 North America Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031)
8.1.2 North America Drug-Loadable Embolic Microspheres Sales by Type (2020-2031)
8.1.3 North America Drug-Loadable Embolic Microspheres Price by Type (2020-2031)
8.2 North America Drug-Loadable Embolic Microspheres Market Size by Application
8.2.1 North America Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031)
8.2.2 North America Drug-Loadable Embolic Microspheres Sales by Application (2020-2031)
8.2.3 North America Drug-Loadable Embolic Microspheres Price by Application (2020-2031)
8.3 North America Drug-Loadable Embolic Microspheres Market Size by Country
8.3.1 North America Drug-Loadable Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Drug-Loadable Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Drug-Loadable Embolic Microspheres Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Drug-Loadable Embolic Microspheres Market Size by Type
9.1.1 Europe Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031)
9.1.2 Europe Drug-Loadable Embolic Microspheres Sales by Type (2020-2031)
9.1.3 Europe Drug-Loadable Embolic Microspheres Price by Type (2020-2031)
9.2 Europe Drug-Loadable Embolic Microspheres Market Size by Application
9.2.1 Europe Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031)
9.2.2 Europe Drug-Loadable Embolic Microspheres Sales by Application (2020-2031)
9.2.3 Europe Drug-Loadable Embolic Microspheres Price by Application (2020-2031)
9.3 Europe Drug-Loadable Embolic Microspheres Market Size by Country
9.3.1 Europe Drug-Loadable Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Drug-Loadable Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Drug-Loadable Embolic Microspheres Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Drug-Loadable Embolic Microspheres Market Size by Type
10.1.1 China Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031)
10.1.2 China Drug-Loadable Embolic Microspheres Sales by Type (2020-2031)
10.1.3 China Drug-Loadable Embolic Microspheres Price by Type (2020-2031)
10.2 China Drug-Loadable Embolic Microspheres Market Size by Application
10.2.1 China Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031)
10.2.2 China Drug-Loadable Embolic Microspheres Sales by Application (2020-2031)
10.2.3 China Drug-Loadable Embolic Microspheres Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Drug-Loadable Embolic Microspheres Market Size by Type
11.1.1 Asia Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031)
11.1.2 Asia Drug-Loadable Embolic Microspheres Sales by Type (2020-2031)
11.1.3 Asia Drug-Loadable Embolic Microspheres Price by Type (2020-2031)
11.2 Asia Drug-Loadable Embolic Microspheres Market Size by Application
11.2.1 Asia Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031)
11.2.2 Asia Drug-Loadable Embolic Microspheres Sales by Application (2020-2031)
11.2.3 Asia Drug-Loadable Embolic Microspheres Price by Application (2020-2031)
11.3 Asia Drug-Loadable Embolic Microspheres Market Size by Country
11.3.1 Asia Drug-Loadable Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Drug-Loadable Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Drug-Loadable Embolic Microspheres Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Drug-Loadable Embolic Microspheres Market Size by Type
12.1.1 SAMEA Drug-Loadable Embolic Microspheres Revenue by Type (2020-2031)
12.1.2 SAMEA Drug-Loadable Embolic Microspheres Sales by Type (2020-2031)
12.1.3 SAMEA Drug-Loadable Embolic Microspheres Price by Type (2020-2031)
12.2 SAMEA Drug-Loadable Embolic Microspheres Market Size by Application
12.2.1 SAMEA Drug-Loadable Embolic Microspheres Revenue by Application (2020-2031)
12.2.2 SAMEA Drug-Loadable Embolic Microspheres Sales by Application (2020-2031)
12.2.3 SAMEA Drug-Loadable Embolic Microspheres Price by Application (2020-2031)
12.3 SAMEA Drug-Loadable Embolic Microspheres Market Size by Country
12.3.1 SAMEA Drug-Loadable Embolic Microspheres Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Drug-Loadable Embolic Microspheres Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Drug-Loadable Embolic Microspheres Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Drug-Loadable Embolic Microspheres Value Chain Analysis
13.1.1 Drug-Loadable Embolic Microspheres Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Drug-Loadable Embolic Microspheres Production Mode & Process
13.2 Drug-Loadable Embolic Microspheres Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Drug-Loadable Embolic Microspheres Distributors
13.2.3 Drug-Loadable Embolic Microspheres Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.